Heptakis(2,6-di-O-methyl)-b-cyclodextrin

Modify Date: 2024-01-02 10:03:54

Heptakis(2,6-di-O-methyl)-b-cyclodextrin Structure
Heptakis(2,6-di-O-methyl)-b-cyclodextrin structure
Common Name Heptakis(2,6-di-O-methyl)-b-cyclodextrin
CAS Number 51166-71-3 Molecular Weight 1331.356
Density 1.4±0.1 g/cm3 Boiling Point 1203.6±65.0 °C at 760 mmHg
Molecular Formula C56H98O35 Melting Point 298 - 310ºC
MSDS Chinese USA Flash Point 681.7±34.3 °C

 Use of Heptakis(2,6-di-O-methyl)-b-cyclodextrin


2,6-Di-O-methyl-β-cyclodextrin is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

 Names

Name 2,6-di-o-methyl-beta-cyclodextrin
Synonym More Synonyms

 Heptakis(2,6-di-O-methyl)-b-cyclodextrin Biological Activity

Description 2,6-Di-O-methyl-β-cyclodextrin is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
Related Catalog

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 1203.6±65.0 °C at 760 mmHg
Melting Point 298 - 310ºC
Molecular Formula C56H98O35
Molecular Weight 1331.356
Flash Point 681.7±34.3 °C
Exact Mass 1330.588867
PSA 400.05000
LogP 6.96
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.553
Storage condition Refrigerator
Water Solubility H2O: soluble

 MSDS

Name: Dimethyl-beta-cyclodextrin 99+% methylated beta-cyclodextrins Material Safety Data Sheet
Synonym: None
CAS: 51166-71-3
Section 1 - Chemical Product MSDS Name:Dimethyl-beta-cyclodextrin 99+% methylated beta-cyclodextrins Material Safety Data Sheet
Synonym:None

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
51166-71-3 Dimethyl-beta-cyclodextrin 99.0+ unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Light sensitive.The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse. Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid. Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Avoid generating dusty conditions. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Store protected from light.
Storage:
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Store protected from light.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 51166-71-3: Personal Protective Equipment Eyes: Wear chemical splash goggles. Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white to pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 298.00 - 310.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: >33g/100ml (25 c)
Specific Gravity/Density:
Molecular Formula: C56H98O35
Molecular Weight: 1331.40

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, light, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 51166-71-3: GU2293500 LD50/LC50:
Not available.
Carcinogenicity:
Dimethyl-beta-cyclodextrin - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 51166-71-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 51166-71-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 51166-71-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GU2293500
CHEMICAL NAME :
beta-Cyclodextrin, 2(sup A),2(sup B),2(sup C),2(sup D),2(sup E),2(sup F),2(sup G),6(sup A),6 (sup B),6(sup C),6(sup D),6(sup E),6(sup F),6(sup G)-tetradeca-O-methyl-
CAS REGISTRY NUMBER :
51166-71-3
LAST UPDATED :
199406
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C56-H98-O35

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
350 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JOIPDF Journal of Inclusion Phenomena. (D. Reidel Publishing Co., c/o Kluwer Academic Publishers, P.O. Box 322, 3300 AH Dordrecht, Netherlands) V.1- 1983- Volume(issue)/page/year: 1,135,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
220 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JOIPDF Journal of Inclusion Phenomena. (D. Reidel Publishing Co., c/o Kluwer Academic Publishers, P.O. Box 322, 3300 AH Dordrecht, Netherlands) V.1- 1983- Volume(issue)/page/year: 1,135,1983
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JOIPDF Journal of Inclusion Phenomena. (D. Reidel Publishing Co., c/o Kluwer Academic Publishers, P.O. Box 322, 3300 AH Dordrecht, Netherlands) V.1- 1983- Volume(issue)/page/year: 1,135,1983
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JOIPDF Journal of Inclusion Phenomena. (D. Reidel Publishing Co., c/o Kluwer Academic Publishers, P.O. Box 322, 3300 AH Dordrecht, Netherlands) V.1- 1983- Volume(issue)/page/year: 1,135,1983

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Safety Phrases 24/25
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS GU2293500
HS Code 29400090

 Synthetic Route

 Articles25

More Articles
Evaluation of the separation mechanism of electrokinetic chromatography with a microemulsion and cyclodextrins using NMR and molecular modeling.

Electrophoresis 32(21) , 3062-9, (2011)

Electrokinetic chromatography (EKC) allows the separation of closely related substances by the detection of fine effects in analyte-separation system interactions. With the goal of understanding the f...

Synthesis, cytotoxicity, and phase-solubility study of cyclodextrin click clusters.

J. Pharm. Sci. 103(10) , 3183-9, (2014)

To explore the possibility of cyclodextrin click clusters (CCCs) as a new cyclodextrin-based excipient, we prepared three different CCCs; heptakis{6-(4-hydroxymethyl-1H-[1,2,3]triazol-1-yl)-6-deoxy}-β...

Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: synthesis, electrochemical, electron spin resonance and molecular modeling studies.

Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 102 , 226-34, (2013)

A new nitrooxoisoaporphine derivative was synthetized and characterized by cyclic voltammetry and electron spin resonance. Its aqueous solubility was improved by complexes formation with β-cyclodextri...

 Synonyms

Dimethyl-beta-cyclodextrin,methylated beta-cyclodextrins
2,6-Di-O-methyl-β-cyclodextrin
Dimethyl β-cyclodextrin
Heptakis(2,6-di-O-methyl)-b-cyclodextrin
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-37,39,41,43,45,47,49-Heptamethoxy-5,10,15,20,25,30,35-heptakis( ;methoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2.2.2.2.2.2]nonatetracontane-36,38,40,42,44,46,48-heptol
MFCD00011616
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37R,38S,39R,40S,41R,42S,43R,44S,45R,46S,47R,48S,49R)-37,39,41,43,45,47,49-Heptamethoxy-5,10,15,20,25,30,35-heptakis(methoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2.2.2.2.2.2]nonatetracontane-36,38,40,42,44,46,48-heptol (non-preferred name)